- Citations, last 5 years
- 6
- Works, last 5 years
- 5
- h-index
- 34
- Scientists listed
- 0
- Grants since 2016
- 2
Grants received
2023–2024 · research · R44
Preclinical and IND enabling studies for treatment of advanced lung cancer and other cancers metastatic to lung by pulmonary delivery of engineered Influenza A Virus (eIAV)
Mallikarjun Srivatsan · Rubius Therapeutics (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Preclinical and IND enabling studies for treatment of advanced lung cancer and other cancers metastatic to lung by pulmonary delivery of engineered Influenza A Virus (eIAV)
Mallikarjun Srivatsan · Rubius Therapeutics (United States) · funded by National Institutes of Health